Amedisys (NASDAQ:AMED) Posts Earnings Results, Misses Estimates By $0.19 EPS

Amedisys (NASDAQ:AMEDGet Free Report) posted its earnings results on Wednesday. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19), Briefing.com reports. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. The company had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same quarter last year, the business posted $0.98 EPS. The firm’s revenue for the quarter was up 5.7% on a year-over-year basis.

Amedisys Trading Down 0.1 %

AMED opened at $96.71 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The stock has a market capitalization of $3.17 billion, a price-to-earnings ratio of 34.54, a PEG ratio of 1.87 and a beta of 0.78. The business has a fifty day moving average price of $96.70 and a 200 day moving average price of $95.82. Amedisys has a 12 month low of $89.55 and a 12 month high of $98.95.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 price objective on shares of Amedisys in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target on the stock. in a research note on Monday, July 29th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, Amedisys has a consensus rating of “Hold” and an average target price of $100.67.

Get Our Latest Research Report on Amedisys

Amedisys Company Profile

(Get Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Recommended Stories

Earnings History for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.